EUVIMEDEUVIMED entdecken
Crossref

Probiotic nanovesicles encapsulating baicalin: a strategy to overcome colorectal cancer

Yifan Li, Xinrui Zhao, Dan Wang, Ruilin Wang, Rui Zhu, Xiaojuan You, Xinwei Liu, Yongwei Li

Letters in Applied Microbiology · 2024

DOI: 10.1093/lambio/ovae117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2024. Verfasst von Yifan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450002, China. Hauptthemen laut MEDLINE: Flavonoids, Probiotics, Colorectal Neoplasms, Escherichia coli. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Gefördert von: Henan Provincial Postdoctoral Research Funding Project, Henan Provincial Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Escherichia coli Nissle 1917 (EcN) is a unique probiotic utilized to treat inflammatory bowel disease and irritable bowel syndrome. Outer membrane vesicles (OMVs) from EcN can not only deliver pro-biotic anti-inflammatory molecules to cancer cells to exert anti-rectal cancer effects, but also deliver therapeutic drugs, genes, and other “cargoes” encapsulated in the vesicles to specific cells, making them an ideal vehicle for drug delivery. In this study, we successfully isolated OMVs of probiotic origin and obtained BCN-OMVs by encapsulating baicalin (BCN) in EcN-OMVs. Fluorescence microscopy showed that both fluorescently labeled EcN-OMVs and BCN-OMVs were able to enter HT-29 cells. The results of CCK-8, plate cloning, flow cytometry, and western blotting indicated that the vitality and proliferation of HT-29 cells were sensibly inhibited after treatment with BCN-OMVs. Additionally, apoptosis-related proteins and proteins involved in the NF-κB pathway were also expressed differently. The results above suggest that EcN-OMVs, serving as a bio-nanocarrier of BCN, can effectively address the limitations of BCN, such as poor water solubility and low bioavailability. They also play a significant anti-tumor role by enhancing cancer cell apoptosis, showing promising potential in targeted therapy for colorectal cancer (CRC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsProbioticsColorectal NeoplasmsEscherichia coliHumansHT29 CellsCell ProliferationCell SurvivalApoptosis

Stichwörter der Autor:innen

Escherichia coli Nissle 1917baicalincolorectal cancerouter membrane vesiclesprobiotic

Substanzen

baicalinFlavonoids

Autor:innen und Institutionen

  • The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450002, China.
  • Hong Kong Baptist University, school of Chinese Medicine,Hong Kong 999077, China.
  • Henan Province Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Chinese Medicine), Zhengzhou 450002, China.

Förderung

  • Henan Provincial Postdoctoral Research Funding Project
  • Henan Provincial Science and Technology Research Project

Zitieren

APA

Li, Y., Zhao, X., Wang, D., Wang, R., Zhu, R., You, X., Liu, X., & Li, Y. (2024). Probiotic nanovesicles encapsulating baicalin: a strategy to overcome colorectal cancer. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovae117

Vancouver

Li Y, Zhao X, Wang D, Wang R, Zhu R, You X, et al. Probiotic nanovesicles encapsulating baicalin: a strategy to overcome colorectal cancer. Letters in Applied Microbiology. 2024. doi:10.1093/lambio/ovae117

BibTeX
@article{Li2024,
  author = {Li, Yifan and Zhao, Xinrui and Wang, Dan and Wang, Ruilin and Zhu, Rui and You, Xiaojuan and Liu, Xinwei and Li, Yongwei},
  title = {Probiotic nanovesicles encapsulating baicalin: a strategy to overcome colorectal cancer},
  journal = {Letters in Applied Microbiology},
  year = {2024},
  doi = {10.1093/lambio/ovae117}
}
Kostenlos starten →